IMU 4.00% 4.8¢ imugene limited

Ann: IMUGENE ANNOUNCES PUBLICATION OF ASCO 2022 PD1-VAXX ABSTRACT, page-48

  1. 5,923 Posts.
    lightbulb Created with Sketch. 1901

    Yes it might sound a little rough .....but true enough l think .

    No point " gilding the lily "

    I'm guessing most of the trial patients would have kicked the bucket over the time line of the trial ( of course we never really can tell )

    Needless to say l dont think we would be having the follow on trials nor the big pharma interest in combo trials etc if there wasnt noteworthy progress .
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.